Pfizer's Art Of The Deal

04:30pm, Wednesday, 01'st Oct 2025
President Trump and Pfizer announced a deal to cut drug pricing yeseterday. And it looks like the pharmaceutical giant got the better end of it.

All Cap Investing With Kirk Spano

03:20pm, Wednesday, 01'st Oct 2025
Kirk Spano runs Margin of Safety Investing and shares what this moment means for all cap investors. Stock picking and options strategies like covered calls and cash-secured puts to generate income and

This 6.75%-Yielding Dividend Stock Can Gain 33%

12:52pm, Wednesday, 01'st Oct 2025
Pfizer (NYSE:PFE) shares are finally starting to attract attention after gaining close to 7% in a single trading session on news that it's reached a pricing deal with the Trump administration.

Stock Of The Day: Will Pfizer Head Higher?

12:13pm, Wednesday, 01'st Oct 2025
Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmac
Pfizer (PFE 5.53%) announced on Tuesday that it had signed an agreement with the White House that will help Americans pay lower prices for prescription drugs and bolster U.S. leadership in biopharmace
Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Tru
Pfizer stock (NYSE: PFE) offers a compelling investment opportunity at its current price of around $25, supported by attractive valuations and recent policy changes that may present further upside pot
President Donald Trump's long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer. Trump's ag
Drug pricing politics in Washington just took a sharp turn. Pfizer Inc (NYSE:PFE, ETR:PFE) has struck a deal with President Trump to support his “Most Favoured Nation” (MFN) plan, which links US
John Lamattina, PureTech Health senior partner and former Pfizer Global R&D president, joins 'Squawk Box' to discuss President Trump's deal with Pfizer, impact on drug prices, what the deal means for
Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. following a demand from President Donald Trump's administration for lower drug prices, the head of a major Swiss chemical
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,
You don't have to invest a fortune to get involved in an industry that could offer your portfolio growth along with safety. I'm talking about the field of healthcare, specifically companies that devel
For more than a century, the stock market has reigned supreme as the most-decorated wealth creator. No asset class has come close to matching the average annual return of stocks -- and with thousands
European healthcare stocks jumped on Wednesday, a day after Pfizer and U.S. President Donald Trump said the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program in exc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE